MINNEAPOLIS – (December 6, 2017) – VigiLanz, a digital healthcare intelligence firm, announced today the launch of a state-of-the-art automation solution that helps hospitals optimize safety event reporting and enhance compliance with accreditation requirements. VigiLanz® Dynamic Safety Surveillance transforms clinical data into actionable intelligence, empowering hospitals to achieve greater risk reduction through automated safety event detection, management and analytics.
Patient falls and adverse drug events are the most common safety events, which also include surgical errors, wrong blood products, injuries to employees and visitors, and workplace violence. As many as 440,000 people die annually from hospital errors, injuries, accidents and infections. To help combat these issues, The Joint Commission made safety event reporting a requirement for accreditation, which uses the information to improve quality and safety of its hospitals.
Despite the importance of safety event reporting, hospitals are confronted with several barriers that prevent a comprehensive accounting of adverse occurrences. These include:
- Limited information on the event
- The time required to complete incident forms
- A lack of urgency to report events considered too minor
- Confusion over reporting responsibilities
VigiLanz Dynamic Safety Surveillance overcomes these obstacles by automating the common approaches to managing, reporting and detecting safety events—including capturing information on serious unsafe conditions and resulting adverse events that previously went unreported.
“Those unreported incidents have the potential to do significant long-term harm, as even minor events can escalate into serious, even deadly, situations,” said VigiLanz Chairman and CEO Dr. David Goldsteen, MD, MBA. “Over-reliance on humans to identify and report safety events exposes hospitals to repercussions ranging from loss of payment for ‘never events’ and damaged reputations to patient grievances and lawsuits. VigiLanz Dynamic Safety Surveillance mitigates those risks with a powerful set of monitoring and reporting tools that supplement human actions for comprehensive reporting.”
VigiLanz Dynamic Safety Surveillance integrates clinical data from multiple sources with comprehensive detection and investigation tools, automated escalation, and a full library of analytical and reporting tools into a single solution that:
- Accelerates the event reporting life cycle through customized workflows
- Converts health data automatically into uniform intelligence for more complete reporting and event detection
- Provides comprehensive tools for efficient analysis
- Generates state of the art dashboards for real-time monitoring
“The business of safety reporting starts with an organizational culture that embraces reporting all safety events,” said Dr. Goldsteen. “VigLanz Dynamic Safety Surveillance takes it to the next level with a tool that facilitates communications about all safety events, including those that might otherwise go unreported.”
For a demonstration of its new Safety Surveillance solution, visit VigiLanz in Booth #212 at the IHI National Forum, taking place Dec. 10-13 in Orlando, Fla.
About VigiLanz
Founded in 2001, VigiLanz Corporation (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS health care intelligence and predictive analytics. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care along the entire health system continuum. VigiLanz supports a large and growing community of hospital CMOs, CMIOs, CIOs, quality teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to real-time inpatient and outpatient care. VigiLanz is shaping the emerging era of real-time health care by delivering enterprise intelligence technology and services that improve clinical outcomes, patient care and operational effectiveness.
AT LEAST 2 MILLION PEOPLE ARE INFECTED WITH ANTIBIOTIC-RESISTANT BACTERIA EACH YEAR. 23,000 DIE AS A DIRECT RESULT.
